Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
24.25    5.15 (26.96%)
Bid:
24.25
Ask:
24.30
Spread: 0.05 (0.206%)
Market Cap: £451.31m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Statement in response to media comment

20 Jun 2016 07:00

RNS Number : 6464B
EnQuest PLC
20 June 2016
 

 

 

ENQUEST PLC, 20 JUNE 2016. 

 

 Statement in response to media comment

 

 

 

EnQuest notes The Telegraph article at the weekend about the UK Oil and Gas Authority's possible North Sea contingency plans. EnQuest routinely engages with the OGA and with the UK and Scottish Governments on industry matters, but is not involved in any company-specific discussions such as were implied by the article.

Ends

 

 

 

 

 

 

 

For further information please contact:

 

EnQuest PLC Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Michael Waring (Head of Communications & Investor Relations)

 

Tulchan Communications Tel: +44 (0)20 7353 4200

Martin Robinson

Martin Pengelley

 

Notes to editors

EnQuest is the largest UK independent producer in the UK North Sea. EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. Its operated assets include the Thistle/Deveron, Heather/ Broom, Dons area, the Greater Kittiwake Area and Alma/Galia, also the Kraken and the Scolty/Crathes developments; EnQuest also has an interest in the non-operated Alba producing oil field. At the start of 2016, EnQuest had interests in 30 UK production licences, covering 42 blocks or part blocks and was the operator of 25 of these licences.

EnQuest believes that the UKCS represents a significant hydrocarbon basin, which continues to benefit from an extensive installed infrastructure base and skilled labour. EnQuest believes that its assets offer material organic growth opportunities, driven by exploitation of current infrastructure on the UKCS and the development of low risk near field opportunities.

 

EnQuest is replicating its model in the UKCS by targeting previously underdeveloped assets in a small number of other maturing regions; complementing its operations and utilising its deep skills in the UK North Sea. In which context, EnQuest has interests in Malaysia where its operated assets include the PM8/Seligi Production Sharing Contract and the Tanjong Baram Risk Services Contract.

 

Forward looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectation and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this presentation should be construed as a profit forecast. Past share performance cannot be relied on as a guide to future performance.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCEASKEALSKEEF
Date   Source Headline
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding
1st Dec 202110:44 amRNSHolding(s) in Company
26th Nov 202110:44 amRNSHolding(s) in Company
24th Nov 20211:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:23 pmRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSOperations update
8th Nov 20213:59 pmRNSHolding(s) in Company
29th Oct 20211:37 pmRNSHolding(s) in Company
25th Oct 20218:05 amRNSRe-admission of Ordinary shares
22nd Oct 20213:02 pmRNSCompletion of Golden Eagle Acquisition
22nd Oct 20211:27 pmRNSHolding(s) in Company
20th Oct 20212:00 pmRNSPublication of Supplementary Prospectus
14th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20215:07 pmRNSPublication of Supplementary Prospectus
29th Sep 202110:29 amRNSHolding(s) in Company
2nd Sep 20217:00 amRNSHalf-year Results
20th Aug 20213:35 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSHolding(s) in Company
30th Jul 20213:22 pmRNSDirector/PDMR Shareholding
29th Jul 202110:18 amRNSHolding(s) in Company
26th Jul 20217:00 amRNSAdmission of New Shares
23rd Jul 202111:21 amRNSResults of Capital Raising and General Meeting
9th Jul 20211:00 pmRNSGeneral Meeting Notice Amendment
6th Jul 20217:00 amRNSBentley transaction completion
30th Jun 20215:12 pmRNSPublication of Combined Circular and Prospectus
30th Jun 20214:17 pmRNSCompletion of Firm Placing and Placing
30th Jun 20217:00 amRNSProposed Firm Placing and Placing and Open Offer
25th May 202110:00 amRNSPayments to governments
12th May 20214:26 pmRNSAGM Statement
12th May 20217:00 amRNSOperations update
5th May 20214:21 pmRNSDirector/PDMR Shareholding
26th Apr 20212:11 pmRNSDirector/PDMR Shareholding
26th Apr 20217:00 amRNSAgreement to acquire Bentley discovery
19th Apr 20213:34 pmRNSDirector/PDMR Shareholding
16th Apr 202110:00 amRNSHolding(s) in Company
15th Apr 20214:31 pmRNSHolding(s) in Company
15th Apr 20214:00 pmRNSAnnual Financial Report
30th Mar 20212:34 pmRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSResults for the year ended 31 December 2020
2nd Mar 20218:00 amRNSHolding(s) in Company
25th Feb 20219:00 amRNSHolding(s) in Company
25th Feb 20217:00 amRNSEagle discovery farm-down
23rd Feb 202111:41 amRNSHolding(s) in Company
22nd Feb 20219:00 amRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
18th Feb 20213:09 pmRNSAdmission to trading
18th Feb 20219:00 amRNSHolding(s) in Company
9th Feb 202110:00 amRNSHolding(s) in Company
5th Feb 20212:49 pmRNSHolding(s) in Company
4th Feb 20215:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.